Exhibit 31(b)

                         CERTIFICATIONS
                         ______________

I, Edward J. Weisberger, certify that:

     1.   I have reviewed this quarterly report on Form 10-QSB of
          IGENE Biotechnology, Inc.;

     2.   Based on my knowledge, this report does not contain any
          untrue statement of a material fact or  omit to state a
          material fact necessary to make the statements made, in
          light  of the circumstances under which such statements
          were  made, not  misleading  with respect to the period
          covered by this report;

     3.   Based  on  my  knowledge, the financial statements, and
          other financial information included  in  this  report,
          fairly present  in  all material respects the financial
          condition, results  of operations and cash flows of the
          small   business  issuer  as  of, and for, the  periods
          presented in this report;

     4.   The small business issuer's other certifying officer(s)
          and I are responsible for establishing and  maintaining
          disclosure  controls  and  procedures  (as  defined  in
          Exchange  Act  Rules  13a-15(e)  and 15d-15(e)) for the
          small business issuer and have:

          (a)  Designed such disclosure controls and  procedures,
          or caused such disclosure controls and procedures to be
          designed under our supervision, to ensure that material
          information  relating  to the  small  business  issuer,
          including its consolidated subsidiaries, is made  known
          to  us  by  others within those entities,  particularly
          during  the  period  in  which  this  report  is  being
          prepared;

          (b)  Evaluated the effectiveness of the small  business
          issuer's   disclosure  controls  and   procedures   and
          presented  in  this  report our conclusions  about  the
          effectiveness   of   the   disclosure   controls    and
          procedures, as of the end of the period covered by this
          report based on such evaluation; and

          (c)  Disclosed in this report any change in  the  small
          business   issuer's  internal  control  over  financial
          reporting  that  occurred  during  the  small  business
          issuer's most recent fiscal quarter (the small business
          issuer's fourth fiscal quarter in the case of an annual
          report)  that has materially affected, or is reasonably
          likely   to  materially  affect,  the  small   business
          issuer's internal control over financial reporting; and

     5.   The small business issuer's other certifying officer(s)
          and  I  have  disclosed,  based  on  our  most   recent
          evaluation   of   internal   control   over   financial
          reporting, to the small business issuer's  auditors and
          the audit committee  of  the  small  business  issuer's
          board of directors (or persons performing the equivalent
          functions):

          (a)   All   significant   deficiencies   and   material
          weaknesses  in  the  design or  operation  of  internal
          control  over financial reporting which are  reasonably
          likely  to adversely affect the small business issuer's
          ability  to  record,  process,  summarize  and   report
          financial information; and

          (b)  Any  fraud, whether or not material, that involves
          management  or  other employees who have a  significant
          role  in  the small business issuer's internal  control
          over financial reporting.

Date: November 11, 2004

      EDWARD J. WEISBERGER
_____________________________
  /s/ EDWARD J. WEISBERGER
      Chief Financial Officer